1. NSD2 Is Recruited through Its PHD Domain to Oncogenic Gene Loci to Drive Multiple Myeloma.
- Author
-
Zheng Huang, Haiping Wu, Chuai, Shannon, Fiona Xu, Feng Yan, Englund, Nathan, Zhaofu Wang, Hailong Zhang, Ming Fang, Youzhen Wang, Gu, Justin, Man Zhang, Yang, Teddy, Kehao Zhao, Yanyan Yu, Jingquan Dai, Wei Yi, Shaolian Zhou, Qian Li, and Jing Wu
- Subjects
- *
GENES , *HEREDITY , *MULTIPLE myeloma , *B cell lymphoma , *HISTONES - Abstract
Histone lysine methyltransferase NSD2 (WHSC1/MMSET) is overexpressed frequently in multiple myeloma due to the t(4;14) translocation associated with 15% to 20% of cases of this disease. NSD2 has been found to be involved in myelomagenesis, suggesting it may offer a novel therapeutic target. Here we show that NSD2 methyltransferase activity is crucial for clonogenicity, adherence, and proliferation of multiple myeloma cells on bone marrow stroma in vitro and that NSD2 is required for tumorigenesis of t(4;14)+ but not t(4;14)- multiple myeloma cells in vivo. The PHD domains in NSD2 were important for its cellular activity and biological function through recruiting NSD2 to its oncogenic target genes and driving their transcriptional activation. By strengthening its disease linkage and deepening insights into its mechanism of action, this study provides a strategy to therapeutically target NSD2 in multiple myeloma patients with a t(4;14) translocation. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF